WAY 100289, endo-N- [(8-methyl-8-azabicyclo [3.2.1 .I octan-3-yl) aminocarbonyll-2cyciopropylmethoxybenzamide, was an antagonist of 5-HT evoked depolarization (5-HT3 receptormediated) of the rat isolated cervical vagus nerve (PA, value 8.9). Schild-plot analysis was consistent with a competitive antagonist mechanism (slope 0.8), though antagonism was not fully surmountable. WAY 100289 was a relatively weak antagonist of 5-HT3 receptor-mediated contractions of the guinea-pig isolated ileum longitudinal muscle-myenteric plexus preparation (PA, value 6.2). In 5-HT3 receptor binding studies in rat entorhinal cortex membranes WAY 100289 displaced [,HIzacopride with a pK, value of 8.4, in good agreement with results in the vagus nerve. In urethane anaesthetised rats the 5-HT evoked Bezold-jarisch reflex was blocked by WAY 100289 with an E D , , of 1.3 pg/kg i.v., consistent with 5-HT3 receptor antagonism. In the conscious rat WAY 100289 was approximately 30-fold more potent by the i.v. than by the p.0. route. Following a dose of 1 mg/kg of WAY 100289 the Bezold-larisch reflex was reduced by more than 50% for in excess of 6 h. In a series of in vitro functional and ligand binding assays WAY 100289 showed good selectivity for the 5-HT3 receptor with the only notable additional activity that of non-competitive antagonism of nicotinic receptor mediated depolarization of the rat vagus nerve (-log IC,, value 6.7). The compound was without significant effect as an inhibitor of the uptake of 5-hydroxytryptamine, noradrenaline or dopamine by rat brain synaptasomes. In general, WAY 100289 is a novel, achira15-HT3 receptor antagonist with good in vitro potency and selectivity and good in vivo activity, oral bioavailability, and duration of action. 0 1993 Wiley-Liss, Inc.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.